According to a report by the co-directors of Boston University's School of Public Health titled, "New Medicare Rx Benefit Means Big Profits for Drug Companies," we have once more failed to sufficiently overestimate what special-interest money can do to legislation written by our elected representatives. According to the report, "An estimated 61.1 percent of the Medicare dollars that will be spent to buy more prescriptions will remain in the hands of drugmakers as added profits."

Isn't that nice? Sixty-one percent of what the plan costs will be additional profit for drug companies. Just what we had in mind. Only our fully-bought-and-paid-for politicians could have taken a plan to help seniors and turned it into a plan to help drug companies already making obscene profits. Their estimated increased profits under this bill are $139 billion over eight years.